SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001493152-22-032681
Filing Date
2022-11-17
Accepted
2022-11-16 20:51:19
Documents
23

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2440916
2 filename2.htm EX-10.2 178305
3 filename3.htm EX-10.13 6014
4 ex10-2_001.jpg GRAPHIC 9089
5 formdrs_004.jpg GRAPHIC 6795
6 formdrs_005.jpg GRAPHIC 53676
7 formdrs_006.jpg GRAPHIC 67500
8 formdrs_007.jpg GRAPHIC 11361
9 formdrs_008.jpg GRAPHIC 11468
10 formdrs_009.jpg GRAPHIC 18507
11 formdrs_010.jpg GRAPHIC 13811
12 formdrs_011.jpg GRAPHIC 25633
13 formdrs_012.jpg GRAPHIC 12952
14 formdrs_013.jpg GRAPHIC 15165
15 formdrs_014.jpg GRAPHIC 22461
16 formdrs_015.jpg GRAPHIC 23615
17 formdrs_017.jpg GRAPHIC 9410
18 ex10-13_001.jpg GRAPHIC 65157
19 ex10-13_002.jpg GRAPHIC 304540
20 ex10-13_003.jpg GRAPHIC 332805
21 ex10-13_004.jpg GRAPHIC 380620
22 ex10-13_005.jpg GRAPHIC 137660
23 ex10-13_006.jpg GRAPHIC 80104
  Complete submission text file 0001493152-22-032681.txt   4834644
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: DRS | Act: 33 | File No.: 377-06462 | Film No.: 221396657
SIC: 2836 Biological Products, (No Diagnostic Substances)